Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |